Results 21 to 30 of about 161,803 (284)

Diagnostic accuracy of PCR in gambiense sleeping sickness diagnosis, staging and post-treatment follow-up: a 2-year longitudinal study. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2011
BACKGROUND:The polymerase chain reaction (PCR) has been proposed for diagnosis, staging and post-treatment follow-up of sleeping sickness but no large-scale clinical evaluations of its diagnostic accuracy have taken place yet.
Stijn Deborggraeve   +7 more
doaj   +1 more source

Sleeping sickness [PDF]

open access: yesTransactions of the Royal Society of Tropical Medicine and Hygiene, 1916
n ...
openaire   +2 more sources

Nifurtimox plus eflornithine for late-stage sleeping sickness in Uganda: A case series [PDF]

open access: yes, 2007
Background: We report efficacy and safety outcomes from a prospective case series of 31 late-stage T. b. gambiense sleeping sickness (Human African Trypanosomiasis, HAT) patients treated with a combination of nifurtimox and eflornithine (N+ E) in Yumbe ...
Thomas, F   +23 more
core   +2 more sources

SLEEPING SICKNESS [PDF]

open access: yesAfrican Affairs, 1903
n ...
openaire   +1 more source

The natural progression of gambiense sleeping sickness: what is the evidence? [PDF]

open access: yes, 2008
Gambiense human African trypanosomiasis (HAT, sleeping sickness) is widely assumed to be 100% pathogenic and fatal. However, reports to the contrary exist, and human trypano-tolerance has been postulated.
Filipe, João AN   +15 more
core   +2 more sources

Probing enzymes late in the trypanosomal glycosylphosphatidylinositol biosynthetic pathway with synthetic glycosylphosphatidylinositol analogues [PDF]

open access: yes, 2008
Glycosylphosphatidylinositol (GPI)-anchored proteins are abundant in the protozoan parasite Trypanosoma brucei, the causative agent of African sleeping sickness in humans and the related disease Nagana in cattle, and disruption of GPI biosynthesis is ...
Nikolaev, Andrei V.   +5 more
core   +5 more sources

Identification of Trypanosome proteins in plasma from African sleeping sickness patients infected with T. b. rhodesiense. [PDF]

open access: yesPLoS ONE, 2013
Control of human African sleeping sickness, caused by subspecies of the protozoan parasite Trypanosoma brucei, is based on preventing transmission by elimination of the tsetse vector and by active diagnostic screening and treatment of infected patients ...
Brett A Eyford   +4 more
doaj   +1 more source

Closing in on a new treatment for sleeping sickness

open access: yeseLife, 2013
A chemoproteomics approach has been employed to identify a kinase that could be used as a druggable target in efforts to develop new treatments for African sleeping sickness.
Emily R Derbyshire, Jon Clardy
doaj   +1 more source

Tsetse elimination: its interest and feasibility in the historical sleeping sickness focus of Loos islands, Guinea

open access: yesParasite, 2009
Guinea is the West African country which is currently the most prevalent for sleeping sickness. The littoral area is the region where most of the recent sleeping sickness cases have been described, especially the mangrove sleeping sickness foci of ...
Kagbadouno M.   +8 more
doaj   +1 more source

Factors affecting the propensity of tsetse flies to enter houses and attack humans inside : increased risk of sleeping sickness in warmer climates [PDF]

open access: yes, 2013
Background: Sleeping sickness, or human African trypanosomiasis, is caused by two species of Trypanosoma brucei that are transmitted to humans by tsetse flies (Glossina spp.) when these insects take a bloodmeal.
Vale Glyn A.   +19 more
core   +2 more sources

Home - About - Disclaimer - Privacy